Recombinant Human FGE protein (denatured)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human FGE protein (denatured) is a Human Fragment protein, in the 91 to 374 aa range, expressed in Escherichia coli, with >85%, suitable for SDS-PAGE.
View Alternative Names
PSEC0152, UNQ3037/PRO9852, SUMF1, Formylglycine-generating enzyme, FGE, C-alpha-formylglycine-generating enzyme 1, Sulfatase-modifying factor 1
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human FGE protein (denatured) (AB115708)
15% SDS-PAGE showing ab115708 at approximately 34.1kDa (3μg).
Reactivity data
Product details
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Formylglycine-generating enzyme contributes significantly to the functionality of sulfatases which carry out essential steps in the degradation of sulfate-containing molecules. This conversion is not a part of a larger complex but enables critical activities through sulfatases. Sulfatases require formylglycine for activity highlighting FGE's role in regulating their presence and function within the cell.
Pathways
Formylglycine-generating enzyme integrates within metabolic pathways involved in glycosaminoglycan degradation. Through this action it connects to proteins like arylsulfatases essential in hydrolyzing sulfate groups from complex carbohydrates. This hydrolysis occurs within the lysosomal degradation pathway where FGE-activated sulfatases function bridging metabolic processes important for cellular maintenance.
Specifications
Form
Liquid
General info
Function
Oxidase that catalyzes the conversion of cysteine to 3-oxoalanine on target proteins, using molecular oxygen and an unidentified reducing agent (PubMed : 12757706, PubMed : 15657036, PubMed : 15907468, PubMed : 16368756, PubMed : 21224894, PubMed : 25931126). 3-oxoalanine modification, which is also named formylglycine (fGly), occurs in the maturation of arylsulfatases and some alkaline phosphatases that use the hydrated form of 3-oxoalanine as a catalytic nucleophile (PubMed : 12757706, PubMed : 15657036, PubMed : 15907468, PubMed : 16368756, PubMed : 25931126). Known substrates include GALNS, ARSA, STS and ARSE (PubMed : 12757706, PubMed : 15657036, PubMed : 15907468).
Sequence similarities
Belongs to the sulfatase-modifying factor family.
Post-translational modifications
N-glycosylated. Contains high-mannose-type oligosaccharides.
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com